Santé & Pharma

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forian Inc.

68 M

Forma Therapeutics Holdings, Inc.

Formycon AG

452 M

Forte Biosciences, Inc.

473 M

Fortress Biotech, Inc.

84 M

Forza Innovations Inc

252 k

Frans Venker

Frans Venker

430 M

Fredun Pharma

Fredun Pharma

13 Md

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

10 Md

Fresenius SE & Co. KGaA

21 Md

Fulcrum Therapeutics, Inc.

461 M

Fulgent Genetics, Inc.

525 M

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE

468 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A. ACQUISISCE CASA DI CURA CITTA’ DI ROMA / GAROFALO HEALTH CARE S.P.A. ACQUIRES CASA DI CURA CITTA' DI ROMA

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI / ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

480 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS ALZA IL RATING DI SOSTENIBILITA' / STANDARD ETHICS RAISES SUSTAINABILITY RATING

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS CONFERMA IL RATING ESG DI BREVE E MEDIO/LUNGO TERMINE / STANDARD ETHICS CONFIRMS SHORT-TERM AND MEDIUM/LONG-TERM ESG RATINGS

GAROFALO HEALTH CARE GHC ACQUISISCE LO STORICO GRUPPO ROMANO DA CUI HA TRATTO LE SUE ORIGINI / GHC ACQUIRES THE HISTORICAL ROMAN GROUP FROM WHICH IT DREW ITS ORIGINS

GAROFALO HEALTH CARE SPA

480 M

GBS Inc.

GBS Inc.

GC메디아이

157 Md

GDR

867 M

GENFIT

425 M

GENOMED S.A.

GENOWAY

30 M

GERON CORP

828 M

GLAUKOS Corp

7,4 Md

GMR Solutions Inc.

628 M

GRAIL, Inc.

2,6 Md

GRIFOLS, S.A

6,5 Md

GRIFOLS, S.A.

6,3 Md

GROUPE TERA

8,1 M

GSK plc

77 Md

GSS

16 M

GT Biopharma, Inc.

20 M

GUERBET

132 M

GVS GVS

GVS SPA

789 M

GW Pharmaceuticals PLC

Gabather AB